BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 19391103)

  • 1. Concepts in in vivo siRNA delivery for cancer therapy.
    Gondi CS; Rao JS
    J Cell Physiol; 2009 Aug; 220(2):285-91. PubMed ID: 19391103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noncoding RNA for Cancer Gene Therapy.
    Zhong X; Zhang D; Xiong M; Zhang L
    Recent Results Cancer Res; 2016; 209():51-60. PubMed ID: 28101687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyethylenimines for siRNA and miRNA delivery in vivo.
    Höbel S; Aigner A
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):484-501. PubMed ID: 23720168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of RNA-triggered gene silencing machineries.
    Li Z; Rana TM
    Acc Chem Res; 2012 Jul; 45(7):1122-31. PubMed ID: 22304792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of RNA interference in cancer therapeutics as a powerful tool for suppressing gene expression.
    He S; Zhang D; Cheng F; Gong F; Guo Y
    Mol Biol Rep; 2009 Nov; 36(8):2153-63. PubMed ID: 19117119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid nanoparticles for short interfering RNA delivery.
    Leung AK; Tam YY; Cullis PR
    Adv Genet; 2014; 88():71-110. PubMed ID: 25409604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small interfering RNA-based molecular therapy of cancers.
    Guo W; Chen W; Yu W; Huang W; Deng W
    Chin J Cancer; 2013 Sep; 32(9):488-93. PubMed ID: 23327796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of In Vivo siRNA Delivery in Cancer Mouse Models.
    Mangala LS; Rodriguez-Aguayo C; Bayraktar E; Jennings NB; Lopez-Berestein G; Sood AK
    Methods Mol Biol; 2021; 2372():157-168. PubMed ID: 34417750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dicey role of Dicer: implications for RNAi therapy.
    Merritt WM; Bar-Eli M; Sood AK
    Cancer Res; 2010 Apr; 70(7):2571-4. PubMed ID: 20179193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in exosome-based nanovehicles as RNA interference therapeutic carriers.
    Maheshwari R; Tekade M; Gondaliya P; Kalia K; D'Emanuele A; Tekade RK
    Nanomedicine (Lond); 2017 Nov; 12(21):2653-2675. PubMed ID: 28960165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on RNA interference-mediated gene silencing in cancer therapy.
    Ren YJ; Zhang Y
    Expert Opin Biol Ther; 2014 Nov; 14(11):1581-92. PubMed ID: 25010067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Challenges in Delivery and Cytosolic Translocation of Therapeutic RNAs.
    Johannes L; Lucchino M
    Nucleic Acid Ther; 2018 Jun; 28(3):178-193. PubMed ID: 29883296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knocking down disease with siRNAs.
    Dykxhoorn DM; Lieberman J
    Cell; 2006 Jul; 126(2):231-5. PubMed ID: 16873051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNAi in clinical studies.
    Kubowicz P; Żelaszczyk D; Pękala E
    Curr Med Chem; 2013; 20(14):1801-16. PubMed ID: 23432579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [SiRNA technology, the gene therapy of the future?].
    Rácz Z; Hamar P
    Orv Hetil; 2008 Jan; 149(4):153-9. PubMed ID: 18201957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA interference--a silent but an efficient therapeutic tool.
    Ramachandran PV; Ignacimuthu S
    Appl Biochem Biotechnol; 2013 Mar; 169(6):1774-89. PubMed ID: 23340870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA interference and cancer therapy.
    Wang Z; Rao DD; Senzer N; Nemunaitis J
    Pharm Res; 2011 Dec; 28(12):2983-95. PubMed ID: 22009588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics.
    Kulkarni JA; Witzigmann D; Chen S; Cullis PR; van der Meel R
    Acc Chem Res; 2019 Sep; 52(9):2435-2444. PubMed ID: 31397996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments in nanoparticle-based siRNA delivery for cancer therapy.
    Lee JM; Yoon TJ; Cho YS
    Biomed Res Int; 2013; 2013():782041. PubMed ID: 23844368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach.
    Mahmoodi Chalbatani G; Dana H; Gharagouzloo E; Grijalvo S; Eritja R; Logsdon CD; Memari F; Miri SR; Rad MR; Marmari V
    Int J Nanomedicine; 2019; 14():3111-3128. PubMed ID: 31118626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.